ICER Presents Alternative Pricing Models for Remdesivir as a Treatment for COVID-19 | ICER

— Models present prices according to two different paradigms: “cost recovery” approach and traditional cost-effectiveness analysis — — Pricing estimates based on preliminary data and will be updated regularly as further data are released and clinical use evolves to include earlier treatment; models will also be used to provide pricing estimates for future treatments as […]

Read the full article here

Related Articles